Your browser doesn't support javascript.
loading
Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The AVENUE Phase 2 Randomized Clinical Trial.
Sahni, Jayashree; Dugel, Pravin U; Patel, Sunil S; Chittum, Mark E; Berger, Brian; Del Valle Rubido, Marta; Sadikhov, Shamil; Szczesny, Piotr; Schwab, Dietmar; Nogoceke, Everson; Weikert, Robert; Fauser, Sascha.
Afiliación
  • Sahni J; Roche Innovation Center Basel, Roche Pharma Research and Early Development, F. Hoffman-La Roche Ltd, Basel, Switzerland.
  • Dugel PU; Retinal Consultants of Arizona, Phoenix.
  • Patel SS; USC Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles.
  • Chittum ME; now affiliated with IVERIC bio, New York, New York.
  • Berger B; West Texas Retina Consultants, Abilene.
  • Del Valle Rubido M; Retina Consultants of Southern Colorado, Colorado Springs.
  • Sadikhov S; Retina Research Center, Austin, Texas.
  • Szczesny P; Roche Innovation Center Basel, Roche Pharma Research and Early Development, F. Hoffman-La Roche Ltd, Basel, Switzerland.
  • Schwab D; Roche Product Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Nogoceke E; Roche Innovation Center Basel, Roche Pharma Research and Early Development, F. Hoffman-La Roche Ltd, Basel, Switzerland.
  • Weikert R; Roche Innovation Center Basel, Roche Pharma Research and Early Development, F. Hoffman-La Roche Ltd, Basel, Switzerland.
  • Fauser S; Roche Innovation Center Basel, Roche Pharma Research and Early Development, F. Hoffman-La Roche Ltd, Basel, Switzerland.
JAMA Ophthalmol ; 138(9): 955-963, 2020 09 01.
Article en En | MEDLINE | ID: mdl-32729888

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Agudeza Visual / Degeneración Macular Húmeda / Ranibizumab / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ophthalmol Año: 2020 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Agudeza Visual / Degeneración Macular Húmeda / Ranibizumab / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ophthalmol Año: 2020 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos